Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
The search for a cure

Drug brings HIV out of hiding

Editor's pick
Nature
9 March 2012
New & experimental HIV treatments

Novel integrase inhibitor dolutegravir still potent at 96 weeks

News
9 March 2012
TB treatment

High dose of new HIV drug might improve outcomes for HIV/TB co-infected

Editor's pick
Science Speaks
8 March 2012
New & experimental HIV treatments

Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study

News
8 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
New & experimental HIV treatments

ViiV's Dolutegravir Continues to Show Well After 96 Weeks, Versus Sustiva, for First-Time Treatment

Editor's pick
AIDSMeds
7 March 2012
Injectable & long-acting PrEP

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

News
7 March 2012
New & experimental HIV treatments

Early Access Program for Integrase Inhibitor Dolutegravir Launched

Editor's pick
AIDSMeds
5 March 2012
New & experimental HIV treatments

Norwegian HIV vaccine—Very modest results seen in recent clinical trial

Editor's pick
CATIE
22 February 2012
HIV treatment

Model Explains Efficacy of HIV Drugs

Editor's pick
MedPage Today
19 February 2012
The search for an HIV prevention vaccine

Results for viral load on Vacc-4x

Editor's pick
Bionor Pharma
16 February 2012
Clinical trials

HIV Experts Propose New Pathway for Conducting Phase 3 Drug Trials

Editor's pick
Forum for Collaborative HIV Research
7 February 2012
New & experimental HIV treatments

New Gilead GS 7340-Inclusive Fixed-Dose Combo Tablet Trial Announced

Editor's pick
AIDSMeds
30 January 2012
New & experimental HIV treatments

Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir

Editor's pick
Gilead press release
24 January 2012
How HIV works

Pathogenic Landscape of HIV

Editor's pick
UCSF Today
21 December 2011
New & experimental HIV treatments

Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Gilead press release
21 December 2011
Pharmaceutical industry

Gilead's New HIV Drug Pipeline: What You Need To Know For 2012

Editor's pick
Seeking Alpha
20 December 2011
New & experimental HIV treatments

Testing nasal vaccine for HIV treatment

Editor's pick
Health Canal
19 December 2011
New & experimental HIV treatments

Novel HIV-Associated Diarrhea Drug Crofelemer Goes to FDA for Approval Review

Editor's pick
AIDSMeds.com
15 December 2011
New & experimental HIV treatments

Aethlon Medical Announces HIV-AIDS Research Discovery

Editor's pick
PR Newswire (press release)
15 December 2011
New & experimental HIV treatments

Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir

Editor's pick
Market Watch
9 December 2011
New & experimental HIV treatments

Boosting Agent Cobicistat Comparable to Norvir in Phase III Study

Editor's pick
AIDSMeds
6 December 2011
Pharmaceutical industry

Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies

Editor's pick
Motley Fool
5 December 2011